These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6356285)

  • 1. Combination antifungal chemotherapy for experimental disseminated candidiasis: lack of correlation between in vitro and in vivo observations with amphotericin B and rifampin.
    Ernst JD; Rusnak M; Sande MA
    Rev Infect Dis; 1983; 5 Suppl 3():S626-30. PubMed ID: 6356285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of rifampin with other antifungal agents in experimental murine candidiasis.
    Graybill JR; Ahrens J
    Rev Infect Dis; 1983; 5 Suppl 3():S620-5. PubMed ID: 6356284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo tests for antimycotic drugs.
    Gargani G; Pini G
    Chemioterapia; 1985 Oct; 4(5):406-12. PubMed ID: 3935334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined amphotericin B and rifampin treatment of experimental Candida albicans keratitis.
    Stern GA; Okumoto M; Smolin G
    Arch Ophthalmol; 1979 Apr; 97(4):721-2. PubMed ID: 426691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of Candida endophthalmitis with a synergistic combination of amphotericin B and rifampin.
    Lou P; Kazdan J; Bannatyne RM; Cheung R
    Am J Ophthalmol; 1977 Jan; 83(1):12-5. PubMed ID: 319671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic action of amphotericin B and rifampin on Candida albicans.
    Beggs WH; Sarosi GA; Andrews FA
    Am Rev Respir Dis; 1974 Nov; 110(5):671-3. PubMed ID: 4611292
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
    Anaissie EJ; Karyotakis NC; Hachem R; Dignani MC; Rex JH; Paetznick V
    J Infect Dis; 1994 Aug; 170(2):384-9. PubMed ID: 8035024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic action of amphotericin B and rifampin against Candida species.
    Beggs WH; Sarosi GA; Walker MI
    J Infect Dis; 1976 Feb; 133(2):206-9. PubMed ID: 1245767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of vaginal trichomoniasis and candidiasis in mice].
    Wildfeuer A
    Arzneimittelforschung; 1974 Jun; 24(6):937-43. PubMed ID: 4603387
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of combination immunotherapy of IgM MAb B6.1 and amphotericin B against disseminated candidiasis.
    Han Y
    Int Immunopharmacol; 2010 Dec; 10(12):1526-31. PubMed ID: 20840836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of modified amphotericin in experimental systemic candidiasis.
    Shkurupy VA; Selyatitskaya VG; Tsyrendorzhiev DD; Pal'chikova NA; Kurilin VV; Travin MA; Nadeev AP; Troitskii AV
    Bull Exp Biol Med; 2007 Apr; 143(4):392-4. PubMed ID: 18214282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice.
    Rabinovich S; Shaw BD; Bryant T; Donta ST
    J Infect Dis; 1974 Jul; 130(1):28-31. PubMed ID: 4601179
    [No Abstract]   [Full Text] [Related]  

  • 13. Disseminated candidiasis due to amphotericin B-resistant Candida albicans.
    Conly J; Rennie R; Johnson J; Farah S; Hellman L
    J Infect Dis; 1992 Apr; 165(4):761-4. PubMed ID: 1285732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo.
    Cacciapuoti A; Gurnani M; Halpern J; Norris C; Patel R; Loebenberg D
    Antimicrob Agents Chemother; 2005 Feb; 49(2):638-42. PubMed ID: 15673745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.
    Deren YT; Ozdek S; Kalkanci A; Akyürek N; Hasanreisoğlu B
    Can J Microbiol; 2010 Jan; 56(1):1-7. PubMed ID: 20130687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
    Ghannoum MA; Okogbule-Wonodi I; Bhat N; Sanati H
    J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mycolase and amphotericin B on Candida albicans and Candida pseudotropicalis in vitro and in vivo.
    Chalkley LJ; Trinci AP; Pope AM
    Sabouraudia; 1985 Jun; 23(3):147-64. PubMed ID: 3895468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergic anticandidal effect of epigallocatechin-O-gallate combined with amphotericin B in a murine model of disseminated candidiasis and its anticandidal mechanism.
    Han Y
    Biol Pharm Bull; 2007 Sep; 30(9):1693-6. PubMed ID: 17827722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia.
    Thaler M; Bacher J; O'Leary T; Pizzo PA
    J Infect Dis; 1988 Jul; 158(1):80-8. PubMed ID: 3392423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
    El-Azizi M; Farag N; Khardori N
    Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.